1. Home
  2. INCR

as of 07-23-2026 12:36pm EST

$0.93
$0.02
-2.40%
Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.

Founded: 1994 Country:
Israel
Israel
Employees: N/A City: N/A
Market Cap: 47.4M IPO Year: 2021
Target Price: N/A AVG Volume (30 days): 19.0K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: N/A EPS Growth: N/A
52 Week Low/High: $0.68 - $1.77 Next Earning Date: 05-01-2026
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): 69.54% Revenue Growth (next year): 41.75%
P/E Ratio: N/A Index: N/A
Free Cash Flow: N/A FCF Growth: N/A

Share on Social Networks: